Xcout Intel
Apollomics Inc.
Apollomics is a biotechnology research company headquartered in Foster City, California, operating through its U.S. headquarters and subsidiaries to develop innovative oncology therapies.
Subscribe to see Apollomics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Apollomics Inc. at a glance
Apollomics Inc. is a healthcare company headquartered in Foster City, United States. It is publicly listed (APLM) with a market capitalisation of $51.7M. Xcout tracks 18 named people at Apollomics Inc., including Hung-Wen Chen (Chief Executive Officer & Chairman of the Board).
Apollomics Inc. leadership
- Hung-Wen ChenChief Executive Officer & Chairman of the Board
- Yi-Kuei ChenDirector & Chief Operating Officer
- K. H. LinChief Financial Officer
- Hung-Wen (Howard) ChenExecutive Officer
- Peter LinExecutive Officer
- Yi-Kuei (Alex) ChenExecutive Officer
12 more named people on record for Apollomics Inc., with roles, board committees and tenure — see the full roster →
Apollomics Inc. competitors
A few of Apollomics Inc.'s closest competitors — see the full list of competitors and alternatives →
Ailomics Therapeutics, founded in 2022 and headquartered in Shanghai, China, is a therapeutics company focused on discovering novel targets.
Alpha BioPharma is a next-generation pharmaceutical and biotechnology company focused on drug development and research. The company establishes strategic partnerships with leading international pharmaceutical organizations and R&D institutes. Its headquarters is located in Shanghai, China.
Filtricine is a biotechnology research company headquartered in Santa Clara, California, founded in 2017. The company focuses on pioneering food-based therapeutic approaches to treat cancer and metabolic diseases.
Portola Pharmaceuticals is an American biotechnology company that researches, develops, and commercializes novel therapeutics. The company primarily focuses on treatments in the areas of thrombosis and hematological malignancies.
Get Apollomics Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Apollomics Inc. in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access